Trial Holdings (141A) Fundamentals 2026 — P/E 39.5x, Revenue Analysis | SniperIQ
Trial Holdings (141A) is a JP-listed Consumer Defensive company in Discount Stores with a market capitalization of ¥368.5B, trading at ¥3005.00 on the JPX. This SniperIQ fundamentals page covers Trial Holdings's valuation (P/E 39.5x, P/B 2.8x), profitability (net margin 0.8%), revenue (¥806.6B in FY2024), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Trial Holdings's market cap?
Trial Holdings (141A) has a market capitalization of approximately ¥368.5B, trading at ¥3005.00 on the JPX. Market cap moves with the live share price.
What is Trial Holdings's P/E ratio?
Trial Holdings's trailing twelve-month P/E ratio is 39.5x, with a price-to-book (P/B) of 2.8x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is Trial Holdings?
Trial Holdings runs a net profit margin of 0.8%, a gross margin of 24.2%, and an operating margin of 2.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Trial Holdings generate?
Trial Holdings reported revenue of ¥806.6B for fiscal year 2024, with net income of ¥11.8B and earnings per share (EPS) of 96.23. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Trial Holdings pay a dividend?
Trial Holdings offers a trailing dividend yield of about 0.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Trial Holdings financially healthy?
Trial Holdings carries a debt-to-equity ratio of 3.00x and a current ratio of 0.32x, with a market beta of 1.19. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Trial Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Trial Holdings (141A) the key facts are: market cap ¥368.5B, P/E 39.5x, revenue ¥806.6B, 52-week range 1996-4840. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track Trial Holdings's full fundamentals live
Get Trial Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.